Our findings will expand the understanding of CD8 + T cell mechanisms in CESC, provide new insights into TME characteristics, and showcase the immense potential of single-cell omics in precision oncology, ultimately facilitating the development of effective immunotherapeutic strategies for CESC patients. Here, CD8A is linked to cervical squamous cell carcinoma.